Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis

Condition:   Chronic Kidney Diseases Interventions:   Drug: Pegol-Sihematide;   Drug: ESPO Sponsor:   Jiangsu Hansoh Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials